Search research articles
Contact Us
Filters
Showing results (201-210 of 251) with videos related to
Page
of 26
Sort By:
Fertility and Sterility
|
April 1, 1995
Randomized trial of partial zona dissection for male infertility
I S Tummon, R E Gore-Langton, S A Daniel, et al.
Paediatric and Perinatal Epidemiology
|
August 9, 2011
Designing prospective cohort studies for assessing reproductive and developmental toxicity during sensitive windows of human reproduction and development--the LIFE Study
Germaine M Buck Louis, Enrique F Schisterman, Anne M Sweeney, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS
|
August 24, 2010
Revised UK guidelines for the management of cutaneous melanoma 2010
J R Marsden, J A Newton-Bishop, L Burrows, et al.
Lancet (London, England)
|
February 24, 2001
Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma
I Vergote, J De Brabanter, A Fyles, et al.
The Lancet. Oncology
|
April 20, 2013
Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial
Robert J Motzer, Bernard Escudier, Piotr Tomczak, et al.
The British Journal of Dermatology
|
October 9, 1998
Comparison of teleconsultations and face-to-face consultations: preliminary results of a United Kingdom multicentre teledermatology study
E Gilmour, S M Campbell, M A Loane, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 23, 2009
A feasibility study of sequential doublet chemotherapy comprising carboplatin-doxorubicin and carboplatin-paclitaxel for advanced endometrial adenocarcinoma and carcinosarcoma
J E Ang, R N Shah, M Everard, et al.
Cancer
|
May 18, 1999
Treatment of nondysgerminomatous ovarian germ cell tumors: an analysis of 69 cases
P L Mitchell, N Al-Nasiri, R A'Hern, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 20, 2012
Evaluation of treatment options for patients with advanced renal cell carcinoma: assessment of appropriateness, using the validated semi-quantitative RAND corporation/University of California, Los Angeles methodology
M E Gore, J Bellmunt, T Eisen, et al.
Addiction Science & Clinical Practice
|
February 28, 2024
Tools to implement measurement-based care (MBC) in the treatment of opioid use disorder (OUD): toward a consensus
A John Rush, Robert E Gore-Langton, Gavin Bart, et al.
Page
of 26
Search research articles
Search
Showing results (201-210 of 251) with videos related to
Sort By:
Page
of 26
Fertility and Sterility
|
April 1, 1995
Randomized trial of partial zona dissection for male infertility
I S Tummon, R E Gore-Langton, S A Daniel, et al.
Paediatric and Perinatal Epidemiology
|
August 9, 2011
Designing prospective cohort studies for assessing reproductive and developmental toxicity during sensitive windows of human reproduction and development--the LIFE Study
Germaine M Buck Louis, Enrique F Schisterman, Anne M Sweeney, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS
|
August 24, 2010
Revised UK guidelines for the management of cutaneous melanoma 2010
J R Marsden, J A Newton-Bishop, L Burrows, et al.
Lancet (London, England)
|
February 24, 2001
Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma
I Vergote, J De Brabanter, A Fyles, et al.
The Lancet. Oncology
|
April 20, 2013
Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial
Robert J Motzer, Bernard Escudier, Piotr Tomczak, et al.
The British Journal of Dermatology
|
October 9, 1998
Comparison of teleconsultations and face-to-face consultations: preliminary results of a United Kingdom multicentre teledermatology study
E Gilmour, S M Campbell, M A Loane, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 23, 2009
A feasibility study of sequential doublet chemotherapy comprising carboplatin-doxorubicin and carboplatin-paclitaxel for advanced endometrial adenocarcinoma and carcinosarcoma
J E Ang, R N Shah, M Everard, et al.
Cancer
|
May 18, 1999
Treatment of nondysgerminomatous ovarian germ cell tumors: an analysis of 69 cases
P L Mitchell, N Al-Nasiri, R A'Hern, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 20, 2012
Evaluation of treatment options for patients with advanced renal cell carcinoma: assessment of appropriateness, using the validated semi-quantitative RAND corporation/University of California, Los Angeles methodology
M E Gore, J Bellmunt, T Eisen, et al.
Addiction Science & Clinical Practice
|
February 28, 2024
Tools to implement measurement-based care (MBC) in the treatment of opioid use disorder (OUD): toward a consensus
A John Rush, Robert E Gore-Langton, Gavin Bart, et al.
Page
of 26